This article reviews the potential role of statins, metformin, and bisphosphonates in cancer prevention. The study examines the mechanisms by which these agents, commonly used for cardiovascular, metabolic, and bone health, may reduce cancer risk. Statins may inhibit tumor growth by targeting cholesterol synthesis pathways, metformin by affecting insulin and
